Characterization of the Microbiome in Peritoneum, Jejunum, Rectum and Stool
NCT ID: NCT04067440
Last Updated: 2025-05-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
30 participants
OBSERVATIONAL
2019-10-01
2024-07-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Advanced Metagenomic Analysis of Human Colonic Microbiota in Patients With Chronic GI Disorders
NCT01099111
A Study to Evaluate the Influence of Diet on GI Health
NCT04783142
Westlake Gut Microbiome Study
NCT04435548
Jejunal Luminal and Colonic Mucosa-Associated Microbiota in Metabolic Diseases: Methods, Identification and Causalities
NCT05186389
The Characteristics and Role of Mucosal Microbiome After Treatment of Clostridioides Difficile Infection
NCT04668014
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The peritoneum is regarded as a sterile place until today. We try to either verify this, we also could find a scientific base for theories like leaky gut or other forms of bacterial migration through the intestinal wall.
Many of these patients undergo bariatric surgery. Many of them do have a dramatic change in glucose metabolism immediate after surgery. Therefore stool swabs will be taken before and 5 days after surgery.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients
Subjects to undergo surgery including opening of the jejunum with non-inflammative condition.
Microbial Swab
Swabs will be taken from peritoneum and jejunum (intraoperatively), rectum, and stool
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Microbial Swab
Swabs will be taken from peritoneum and jejunum (intraoperatively), rectum, and stool
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* singing of consent
Exclusion Criteria
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Universität des Saarlandes
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Michael Jelden
Dr. med. Michael Jelden
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Michael Jelden, Dr.
Role: PRINCIPAL_INVESTIGATOR
Saarland University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of General, Visceral, Vascular and Pediatric Surgery, University of Saarland,
Homburg/Saar, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
METABIOM
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.